About Retriever Medical

The startup manufactures medical equipment focused on novel aspiration catheters, mechanical thrombectomy devices, and blood filtration systems for managing thromboembolic vaso-occlusive conditions. Their integrated system enables clinicians to efficiently perform complex surgeries and treat acute, subacute, and chronic vascular blockages.

```xml <problem> Current methods for removing thrombi from blood vessels can be inefficient, particularly when dealing with clots of varying composition and adherence. Existing thrombectomy devices may struggle to fully extract clots, leading to incomplete recanalization and potential for distal embolization. Significant blood loss during aspiration procedures also remains a concern.</problem> <solution> Retriever Medical develops and manufactures aspiration catheters and mechanical thrombectomy devices designed for efficient removal of thromboembolic material from the pulmonary and peripheral vasculature. Their ClotHound ACE system features specialized catheters engineered to remove soft, organized, impacted, and wall-adherent clots. The BloodHound BOSS system works in conjunction with the ClotHound system, filtering aspirated thrombus and blood, allowing for immediate reinfusion of blood back to the patient, thereby minimizing blood loss during the procedure. The company's focus is on creating atraumatic designs that optimize clot removal while minimizing damage to the vessel wall.</solution> <features> - ClotHound ACE Gold PE: Optimized for removing soft, organized, impacted, and wall-adherent clots in pulmonary embolism (PE) procedures. - ClotHound ACE Blue DVT: Optimized for removing soft, organized, and wall-adherent clots in deep vein thrombosis (DVT) procedures. - DogLeg 24F and DogCurve 20F Large Bore Aspiration Catheters: Designed for pulmonary clot removal. - DogTail 16F Aspiration Catheter: Designed for DVT clot removal. - BloodHound BOSS: Blood filtration system designed to minimize blood loss during thrombectomy by allowing for immediate reinfusion of filtered blood. - Atraumatic catheter designs to minimize vessel wall damage. </features> <target_audience> The primary target audience includes interventional cardiologists, vascular surgeons, and interventional radiologists who perform thrombectomy procedures for pulmonary embolism and deep vein thrombosis. </target_audience> ```

What does Retriever Medical do?

Where is Retriever Medical located?

Retriever Medical is based in Las Vegas, United States.

When was Retriever Medical founded?

Retriever Medical was founded in 2020.

How much funding has Retriever Medical raised?

Retriever Medical has raised 12120000.

Location

Las Vegas, United States

Founded

2020

Funding

12120000

Employees

4 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Retriever Medical

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

rtvmed.com 300+

Founded 2020 – Las Vegas, United States

Funding

Estimated Funding

$10M+

Team (<5)

No team information available.

Company Description

Problem

Current methods for removing thrombi from blood vessels can be inefficient, particularly when dealing with clots of varying composition and adherence. Existing thrombectomy devices may struggle to fully extract clots, leading to incomplete recanalization and potential for distal embolization. Significant blood loss during aspiration procedures also remains a concern.

Solution

Retriever Medical develops and manufactures aspiration catheters and mechanical thrombectomy devices designed for efficient removal of thromboembolic material from the pulmonary and peripheral vasculature. Their ClotHound ACE system features specialized catheters engineered to remove soft, organized, impacted, and wall-adherent clots. The BloodHound BOSS system works in conjunction with the ClotHound system, filtering aspirated thrombus and blood, allowing for immediate reinfusion of blood back to the patient, thereby minimizing blood loss during the procedure. The company's focus is on creating atraumatic designs that optimize clot removal while minimizing damage to the vessel wall.

Features

ClotHound ACE Gold PE: Optimized for removing soft, organized, impacted, and wall-adherent clots in pulmonary embolism (PE) procedures.

ClotHound ACE Blue DVT: Optimized for removing soft, organized, and wall-adherent clots in deep vein thrombosis (DVT) procedures.

DogLeg 24F and DogCurve 20F Large Bore Aspiration Catheters: Designed for pulmonary clot removal.

DogTail 16F Aspiration Catheter: Designed for DVT clot removal.

BloodHound BOSS: Blood filtration system designed to minimize blood loss during thrombectomy by allowing for immediate reinfusion of filtered blood.

Atraumatic catheter designs to minimize vessel wall damage.

Target Audience

The primary target audience includes interventional cardiologists, vascular surgeons, and interventional radiologists who perform thrombectomy procedures for pulmonary embolism and deep vein thrombosis.